ArticleCureus2026
Texture Analysis of Kidney MRI Using Diffusion-Weighted Imaging and Intravoxel Incoherent Motion for Classifying the Severity of Chronic Kidney Diseases.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Kidney MRI Texture Analysis-A Universal Assessment of Kidney State and Function?Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Chronic kidney disease (CKD) is a significant global health concern, and noninvasive imaging biomarkers for chronic kidney disease have been investigated using magnetic resonance imaging (MRI), including diffusion‑weighted imaging (DWI), blood oxygenation level-dependent (BOLD) imaging, arterial spin labeling (ASL), and T1 mapping; however, there are currently no widely accepted imaging biomarkers for the non-invasive assessment of renal dysfunction severity. DWI and intravoxel incoherent motion (IVIM), when combined with texture analysis (TA), provide a promising approach for the non-invasive assessment of renal microstructure. This study investigated the utility of TA applied to DWI/IVIM-derived maps for assessing the severity of renal dysfunction. Materials and methods We retrospectively analyzed kidney MRI data from 68 patients with CKD who underwent DWI-IVIM. Data were categorized into three groups based on the estimated glomerular filtration rates (eGFRs). Two-dimensional segmentation was performed on the apparent diffusion coefficient (ADC), true diffusion coefficient, pseudo-perfusion diffusion coefficient, and perfusion fraction map. After extracting 93 texture features (TFs), we employed a sequential feature selection algorithm for feature selection. Multiclass classification models were developed using linear discriminant analysis, quadratic discriminant analysis (QDA), support vector machines, k-nearest neighbors, decision trees, and random forest classifiers. To evaluate model performance, we performed a 10‑fold cross‑validation 100 times and used the mean of the resulting performance measures as the performance estimate. Results TA models demonstrated acceptable discriminatory performance, with the highest performance achieved by the ADC map-based QDA model (area under the curve or AUC 0.851±0.010). The IVIM-derived parameters did not outperform the ADC-based models. TFs derived from the left kidney showed slightly better results than those derived from the right kidney. There were no significant differences between TFs derived from the renal medulla and the cortex. Conclusion Although the combination of DWI-IVIM and TA has the potential to evaluate renal impairment in patients with CKD, the TA model based on the ADC map achieved higher accuracy than the models based on other IVIM parameters. Consequently, the utility of TA using ADC maps was reaffirmed. Future research with larger cohorts and improved image quality is needed to further refine the non-invasive assessment of renal dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.